CAS 956483-03-7

FV-100

CAS : 956483-03-7

FV-100

Degré de pureté : ≥98%

Masse moléculaire : 534.04g/mol

Ref: 54-BUP11637

FV-100

CAS : 956483-03-7

FV-100 (Valnivudine HCl), API for CF-1743, is a potent, oral anti-vaxx-zoster drug with low in vivo toxicity.

Formule : C₂₇H₃₆ClN₃O₆

Degré de pureté : 98.52%

Couleur et forme : Solid

Masse moléculaire : 534.04

Ref: TM-T41116

Valnivudine hydrochloride

CAS : 956483-03-7

Valnivudine hydrochloride is an antiviral drug that inhibits the replication of herpes viruses by inhibiting viral DNA polymerase. It is used to treat shingles and post-herpetic neuralgia. Valnivudine hydrochloride has been shown to be effective in reducing the severity and duration of symptoms, as well as reducing significant morbidity, when given to patients with shingles or post-herpetic neuralgia. Valnivudine hydrochloride also has a role in the prevention of transmission of HIV from mother to child during pregnancy, childbirth, and breastfeeding.

Formule : C₂₇H₃₆ClN₃O₆

Degré de pureté : Min. 95%

Masse moléculaire : 534 g/mol

Ref: 3D-FV180234

FV 100-d7 (Major)

Produit contrôlé

CAS : 956483-02-6, 956483-03-7

Applications FV 100-d7 is labelled FV 100 (F870000), an orally available nucleoside analogue prodrug of CF-1743 (C291710) which is used for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV.
References McGuigan, C., et al.: J. Med. Chem., 43, 4993 (2000); McGuigan, C., et al.: J. Antimicro. Chemother., 60, 1316 (2007); Andrei, G., et al.: Antimicro. Agents Chemother., 49, 1081 (2005)

Formule : C₂₇D₇H₂₈N₃O₆

Couleur et forme : Neat

Masse moléculaire : 504.626

Ref: TR-F870002

FV 100 Hydrochloride

Produit contrôlé

CAS : 956483-03-7

Formule : C₂₇H₃₅N₃O₆·ClH

Couleur et forme : Neat

Masse moléculaire : 534.044

Ref: TR-F871000